ANI PHARMACEUTICALS INC (ANIP)

US00182C1036 - Common Stock

65.36  +0.41 (+0.63%)

After market: 62.35 -3.01 (-4.61%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
486.82M316.40M216.10M208.50M206.50M
Cost Of Goods
181.51M138.80M100.60M87.20M63.20M
Gross Profit
305.30M177.60M115.50M121.30M143.40M
Operating Expenses
257.20M207.10M143.40M125.60M120.20M
Research and Development
34.29M22.30M11.40M16.00M19.80M
Selling, General, and Administrative Expenses
161.70M124.00M84.30M65.00M55.80M
Operating Income
48.10M-29.50M-27.90M-4.30M23.20M
Interest Income/Expense
-26.94M-28.10M-11.90M-9.50M-13.00M
Other Income/Expense
-159.00K700.00K-4.30M-500.00K-200.00K
Non Recurring Items
-1.13M-5.80M-11.90M-11.70M-6.80M
Income Before Taxes
19.87M-62.70M-56.10M-26.00M3.20M
Income Tax
1.09M-14.80M-13.50M-3.40M-2.90M
Net Income
15.47M-49.50M-42.80M-22.50M6.00M
EBITDA
107.89M30.15M19.35M40.34M67.81M
 
Per Share Data
EPS Diluted Total Ops
0.85-3.05-3.40-1.880.50
Non GAAP EPS
4.721.413.263.505.05
 
Statistics
Gross Profit Margin
62.71%56.13%53.45%58.18%69.44%
Profit Margin
3.18%-15.64%-19.81%-10.79%2.91%
Operating Profit Margin
9.88%-9.32%-12.91%-2.06%11.23%

All data in USD

Charts